|
|
||||||||
The Crump Institute and the Division of Nuclear Medicine and Biophysics, UCLA School of Medicine, Los Angeles, California
Department of Nuclear Medicine, Royal Prince Alfred Hospital, Sydney, Australia
Correspondence: For reprints or correspondence contact: Simon R. Cherry, Division of Nuclear Medicine & Biophysics, UCLA School of Medicine, Los Angeles, CA 90024-1721.
ABSTRACT
Large sensitivity increases are realized in positron emission tomography when the interplane septa are removed and all lines of response acquired. Unfortunately, three-dimensional acquisition results in a large increase in scatter fraction which prevents accurate quantitation. By acquiring short two-dimensional scans prior to three-dimensional ones, scatter distributions can be estimated from differences between lines of response common to both data sets. This initial scatter distribution can be further modified to approximate scatter in the entire three-dimensional dataset. The method was validated with phantom measurements in which absolute activity concentrations were known in all compartments. Following scatter correction, a four-compartment phantom that was nonuniform in activity and density, both axially and transaxially, gave activity concentrations of 0.45 ± 0.02, 0.31 ± 0.02, 0.01 ± 0.01 and 0.01 ± 0.01 µCi/cc for compartments containing 0.43, 0.29, 0.0 (air) and 0.0 (water) µCi/cc, respectively. Thus, scatter distributions for complex sources can be estimated from image data without lengthy Monte-Carlo simulations. When activity distributions vary slowly with time, this method can be used to correct for scatter in three-dimensional patient studies.
This article has been cited by other articles:
![]() |
C. Lartizien, C. Comtat, P. E. Kinahan, N. Ferreira, B. Bendriem, and R. Trebossen Optimization of Injected Dose Based on Noise Equivalent Count Rates for 2- and 3-Dimensional Whole-Body PET J. Nucl. Med., September 1, 2002; 43(9): 1268 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Contag, S. Fraser, and R. Weissleder Strategies in In Vivo Molecular Imaging NeoReviews, December 1, 2000; 1(12): e225 - 232. [Full Text] |
||||
![]() |
J. S. Rakshi, T. Uema, K. Ito, D. L. Bailey, P. K. Morrish, J. Ashburner, A. Dagher, I. H. Jenkins, K. J. Friston, and D. J. Brooks Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study Brain, September 1, 1999; 122(9): 1637 - 1650. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |